Jakob Nikolas Kather, PhD, MSc The third Annual Meeting Plenary Session, “AI Revolution in Cancer Research,” highlighted advances in artificial intelligence (AI) tools for cancer research and care. The session opened with a quick review from Session Chair Jakob Nikolas Kather, PhD, MSc, of Technische Universität Dresden in Germany. Kather explained that in the 2000s, AI’s role in biomedical research focused on what are now termed classical machi…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.